<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM12115</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-12115</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Современные подходы к диагностике диабетического макулярного отека</article-title><trans-title-group xml:lang="en"><trans-title>Modern aproaches to diabetic macular edema diagnosticks</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2519-8941</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дога</surname><given-names>Александр Викторович</given-names></name><name name-style="western" xml:lang="en"><surname>Doga</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф.</p></bio><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><email xlink:type="simple">alexander_doga@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1460-9960</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Володин</surname><given-names>Павел Львович</given-names></name><name name-style="western" xml:lang="en"><surname>Volodin</surname><given-names>P. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н.</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">plvmd@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9044-3400</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванова</surname><given-names>Елена Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">elena-mntk@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4528-1446</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буряков</surname><given-names>Дмитрий Анатольевич</given-names></name><name name-style="western" xml:lang="en"><surname>Buryakov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">buryakov.da@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитин</surname><given-names>Олег Игоревич</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitin</surname><given-names>O. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант</p></bio><bio xml:lang="en"><p>PhD student</p></bio><email xlink:type="simple">olegnikitin@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5250-3684</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авакян</surname><given-names>Флора Артуровна</given-names></name><name name-style="western" xml:lang="en"><surname>Avakyan</surname><given-names>F&gt; A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ординатор</p></bio><bio xml:lang="en"><p>clinical resident</p></bio><email xlink:type="simple">avakyan.flora@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр «Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>The S. Fyodorov Eye Microsurgery Federal State Institution</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>10</day><month>08</month><year>2020</year></pub-date><volume>23</volume><issue>3</issue><fpage>260</fpage><lpage>266</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Дога А.В., Володин П.Л., Иванова Е.В., Буряков Д.А., Никитин О.И., Авакян Ф.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Дога А.В., Володин П.Л., Иванова Е.В., Буряков Д.А., Никитин О.И., Авакян Ф.А.</copyright-holder><copyright-holder xml:lang="en">Doga A.V., Volodin P.L., Ivanova E.V., Buryakov D.A., Nikitin O.I., Avakyan F.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/12115">https://www.dia-endojournals.ru/jour/article/view/12115</self-uri><abstract><p>Диабетический макулярный отек (ДМО) на сегодняшний день продолжает оставаться важной проблемой современной офтальмологии и эндокринологии. Риск возникновения отека выше у пациентов с сахарным диабетом 2 типа. Таким образом, это является основной причиной необратимой потери зрения у таких пациентов. ДМО – один из прогностически неблагоприятных и тяжело поддающихся лечению проявлений диабетической ретинопатии. ­Являясь основной причиной снижения зрения у больных сахарным диабетом, ДМО зачастую диагностируется не сразу, что и служит причиной возникновения трудностей в лечении патологии. Таким образом, именно ранняя диагностика и своевременное лечение данного заболевания являются залогом успешного противодействия неконтролируемому падению зрительных функций пациента. В данной статье коллектив авторов осветил возможности информативных инструментальных методов исследования, имеющихся в арсенале современной офтальмологической службы. На основе анализа современной литературы были указаны основные принципы работы этих диагностических методов, выделены их ключевые возможности и ограничения по сравнению друг с другом. Знание этих характеристик является, на наш взгляд, неотъемлемым и важнейшим инструментом в арсенале практикующего врача-офтальмолога, курирующего пациентов с данной патологией.</p></abstract><trans-abstract xml:lang="en"><p>Diabetic macular edema (DME) continues to be an important problem of modern ophthalmology and endocrinology. The risk of edema is higher in patients with type 2 diabetes. Thus, this is the main cause of irreversible vision loss in these patients. DME is one of the prognostically unfavorable and difficult to treat manifestations of diabetic retinopathy. As the main cause of vision loss in diabetic patients, diabetic macular edema is often not diagnosed immediately, which causes difficulties in the treatment of pathology. Thus, early diagnosis and timely treatment of this disease is the key to successfully counteract the uncontrolled decline in the patient’s visual functions.</p><p>In this article, the team of authors highlighted the possibilities of informative instrumental research methods available in the Arsenal of modern ophthalmological services. Based on the analysis of modern literature, the main principles of these diagnostic methods were indicated, their key capabilities and limitations compared to each other were highlighted. Knowledge of these characteristics is, in our opinion, an integral and most important tool in the Arsenal of a practicing ophthalmologist who supervises patients with this pathology.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет</kwd><kwd>диабетический макулярный отек</kwd><kwd>диабетическая ретинопатия</kwd><kwd>оптическая когерентная томография</kwd><kwd>ангиография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus</kwd><kwd>diabetic macular edema</kwd><kwd>diabetic retinopathy</kwd><kwd>optical coherence tomography</kwd><kwd>angiography</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Трахтенберг Ю.А., Аметов А.С., Демидова Т.Ю., Воробьева И.В. Антиоксидантная терапия непролиферативной диабетической ретинопатии // Врач. — 2006. — №11. — С. 36–39. [Trakhtenberg YuA, Ametov AS, Demidova TYu, Vorob’eva IV. Antioksidantnaya terapiya neproliferativnoy diabeticheskoy retinopatii. Vrach. 2006;(11):36-39. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Трахтенберг Ю.А., Аметов А.С., Демидова Т.Ю., Воробьева И.В. Антиоксидантная терапия непролиферативной диабетической ретинопатии // Врач. — 2006. — №11. — С. 36–39. [Trakhtenberg YuA, Ametov AS, Demidova TYu, Vorob’eva IV. Antioksidantnaya terapiya neproliferativnoy diabeticheskoy retinopatii. Vrach. 2006;(11):36-39. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">White NH, Sun W, Cleary PA, et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 2010;59(5):1244-1253. doi: https://doi.org/10.2337/db09-1216</mixed-citation><mixed-citation xml:lang="en">White NH, Sun W, Cleary PA, et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 2010;59(5):1244-1253. doi: https://doi.org/10.2337/db09-1216</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bhagat N, Grigorian R, Tutela A, Zarbin M. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54(1):1-32. doi: https://doi.org/10.1016/j.survophthal.2008.10.001</mixed-citation><mixed-citation xml:lang="en">Bhagat N, Grigorian R, Tutela A, Zarbin M. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54(1):1-32. doi: https://doi.org/10.1016/j.survophthal.2008.10.001</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Балашевич Л.И. Глазные проявления диабета. — СПб.: МАПО, 2004. — 382 с. [Balashevich LI. Glaznye proyavleniya diabeta. Saint Petersburg: Medical Academy of Post-Graduate Education; 2004. 382 p. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Балашевич Л.И. Глазные проявления диабета. — СПб.: МАПО, 2004. — 382 с. [Balashevich LI. Glaznye proyavleniya diabeta. Saint Petersburg: Medical Academy of Post-Graduate Education; 2004. 382 p. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Балашевич Л.И., Измайлов А.С. Диабетическая офтальмопатия. — СПб.: Человек, 2012. — 336 с. [Balashevich LI, Izmaylov AS. Diabeticheskaya oftal’mopatiya. Saint Petersburg: Chelovek; 2012. 336 p. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Балашевич Л.И., Измайлов А.С. Диабетическая офтальмопатия. — СПб.: Человек, 2012. — 336 с. [Balashevich LI, Izmaylov AS. Diabeticheskaya oftal’mopatiya. Saint Petersburg: Chelovek; 2012. 336 p. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Haller JA, Schachat AP. Update on the pathophisiology, molecular biology, and treatment of macular edema. Advanced studies in ophthalmology. 2007;4(7):178-190.</mixed-citation><mixed-citation xml:lang="en">Haller JA, Schachat AP. Update on the pathophisiology, molecular biology, and treatment of macular edema. Advanced studies in ophthalmology. 2007;4(7):178-190.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Романенко И.А., Черкасова В.В., Егоров Е.А. Диабетический макулярный отек. Классификация, клиника, лечение // РМЖ. Клиническая офтальмология. — 2010. — Т. 11. — №1. — С. 30–32. [Romanenko IA, Cherkasova VV, Egorov EA. Diabetic macular edema. Classification, clinic, treatment. RMZh. Klinicheskaia oftal’mologiia. 2010;11(1):30-32. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Романенко И.А., Черкасова В.В., Егоров Е.А. Диабетический макулярный отек. Классификация, клиника, лечение // РМЖ. Клиническая офтальмология. — 2010. — Т. 11. — №1. — С. 30–32. [Romanenko IA, Cherkasova VV, Egorov EA. Diabetic macular edema. Classification, clinic, treatment. RMZh. Klinicheskaia oftal’mologiia. 2010;11(1):30-32. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bernardes R, Dias J, Cunha-Vaz J. Mapping the human blood-retinal barrier function. IEEE Trans Biomed Eng . 2005;52(1):106-116. doi: https://doi.org/10.1109/TBME.2004.839801</mixed-citation><mixed-citation xml:lang="en">Bernardes R, Dias J, Cunha-Vaz J. Mapping the human blood-retinal barrier function. IEEE Trans Biomed Eng . 2005;52(1):106-116. doi: https://doi.org/10.1109/TBME.2004.839801</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gardner TW, Aiello LP. Pathogenesis of diabetic retinopathy. In: Flynn HW, Smiddy WE. Diabetes and ocular disease: past, present and future therapies. Ophthalmology monographs. N-Y; 2000. Р. 49-70.</mixed-citation><mixed-citation xml:lang="en">Gardner TW, Aiello LP. Pathogenesis of diabetic retinopathy. In: Flynn HW, Smiddy WE. Diabetes and ocular disease: past, present and future therapies. Ophthalmology monographs. N-Y; 2000. Р. 49-70.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Soheilian M, Ramezani A, Obudi A, et al. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Ophthalmology. 2009;116(6):1142-1150. doi: https://doi.org/10.1016/j.ophtha.2009.01.011</mixed-citation><mixed-citation xml:lang="en">Soheilian M, Ramezani A, Obudi A, et al. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Ophthalmology. 2009;116(6):1142-1150. doi: https://doi.org/10.1016/j.ophtha.2009.01.011</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Stefánsson E. Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol. 2006;51(4):364-380. doi: https://doi.org/10.1016/j.survophthal.2006.04.005</mixed-citation><mixed-citation xml:lang="en">Stefánsson E. Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol. 2006;51(4):364-380. doi: https://doi.org/10.1016/j.survophthal.2006.04.005</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bhagat N, Grigorian R, Tutela A, Zarbin N. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54(1):1-32. doi: https://doi.org/10.1016/j.survophthal.2008.10.001</mixed-citation><mixed-citation xml:lang="en">Bhagat N, Grigorian R, Tutela A, Zarbin N. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54(1):1-32. doi: https://doi.org/10.1016/j.survophthal.2008.10.001</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Vujosevic S, Casciano M, Pilotto E, et al. Diabetic macular edema: fundus autofluorescence and functional correlations. Invest Ophthalmol Vis Sci. 2011; 52(1):442-448. doi: https://doi.org/10.1167/iovs.10-5588</mixed-citation><mixed-citation xml:lang="en">Vujosevic S, Casciano M, Pilotto E, et al. Diabetic macular edema: fundus autofluorescence and functional correlations. Invest Ophthalmol Vis Sci. 2011; 52(1):442-448. doi: https://doi.org/10.1167/iovs.10-5588</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Vujosevic S, Pilotto E, Bottega E, et al. Retinal fixation impairment in diabetic macular edema. Retina. 2008;28(10):1443-1450. doi: https://doi.org/10.1097/IAE.0b013e318183571e</mixed-citation><mixed-citation xml:lang="en">Vujosevic S, Pilotto E, Bottega E, et al. Retinal fixation impairment in diabetic macular edema. Retina. 2008;28(10):1443-1450. doi: https://doi.org/10.1097/IAE.0b013e318183571e</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wirostko B, Wong TY, Simo R. Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res. 2008;27(6):608-621. doi: https://doi.org/10.1016/j.preteyeres.2008.09.002</mixed-citation><mixed-citation xml:lang="en">Wirostko B, Wong TY, Simo R. Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res. 2008;27(6):608-621. doi: https://doi.org/10.1016/j.preteyeres.2008.09.002</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Virgili G, Menchini F, Murro V, et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2011;6(7):CD008081. doi: https://doi.org/10.1002/14651858.CD008081.pub2</mixed-citation><mixed-citation xml:lang="en">Virgili G, Menchini F, Murro V, et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2011;6(7):CD008081. doi: https://doi.org/10.1002/14651858.CD008081.pub2</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Luo X, Frishman LJ. Retinal Pathway Origins of the Pattern Electroretinogram (PERG). Invest Ophthalmol Vis Sci. 2011;52(12):8571-8584. doi: https://doi.org/10.1167/iovs.11-8376</mixed-citation><mixed-citation xml:lang="en">Luo X, Frishman LJ. Retinal Pathway Origins of the Pattern Electroretinogram (PERG). Invest Ophthalmol Vis Sci. 2011;52(12):8571-8584. doi: https://doi.org/10.1167/iovs.11-8376</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Park HY, Kim IT, Park CK. Early diabetic changes in the nerve fibre layer at the macula detected by spectral domain optical coherence tomography. Br J Ophthalmol. 2011;95(9):1223-1228. doi: https://doi.org/10.1136/bjo.2010.191841</mixed-citation><mixed-citation xml:lang="en">Park HY, Kim IT, Park CK. Early diabetic changes in the nerve fibre layer at the macula detected by spectral domain optical coherence tomography. Br J Ophthalmol. 2011;95(9):1223-1228. doi: https://doi.org/10.1136/bjo.2010.191841</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Peng PH, Lin HS, Lin S. Nerve fibre layer thinning in patients with preclinical retinopathy. Can J Ophthalmol. 2009;44(4):417-422. doi: https://doi.org/10.3129/i09-112</mixed-citation><mixed-citation xml:lang="en">Peng PH, Lin HS, Lin S. Nerve fibre layer thinning in patients with preclinical retinopathy. Can J Ophthalmol. 2009;44(4):417-422. doi: https://doi.org/10.3129/i09-112</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Sakata K, Funatsu H, Harino S, et al. Relationship of macular microcirculation and retinal thickness with visual acuity in diabetic macular edema. Ophthalmology. 2007;114(11):2061-2069. doi: https://doi.org/10.1016/j.ophtha.2007.01.003</mixed-citation><mixed-citation xml:lang="en">Sakata K, Funatsu H, Harino S, et al. Relationship of macular microcirculation and retinal thickness with visual acuity in diabetic macular edema. Ophthalmology. 2007;114(11):2061-2069. doi: https://doi.org/10.1016/j.ophtha.2007.01.003</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Бикбов М.М., Файзрахманов Р.Р., Зайнуллин Р.М., и др. Макулярный отек как проявление диабетической ретинопатии // Сахарный диабет. — 2017. — Т. 20. — №4. — С. 263–269. [Bikbov MM, Fayzrakhmanov RR, Zaynullin RM. Macular oedema as manifestation of diabetic retinopathy. Diabetes Mellitus. 2017;20(4):263–269. (In Russ.)]. doi: https://doi.org/10.14341/DM8328</mixed-citation><mixed-citation xml:lang="en">Бикбов М.М., Файзрахманов Р.Р., Зайнуллин Р.М., и др. Макулярный отек как проявление диабетической ретинопатии // Сахарный диабет. — 2017. — Т. 20. — №4. — С. 263–269. [Bikbov MM, Fayzrakhmanov RR, Zaynullin RM. Macular oedema as manifestation of diabetic retinopathy. Diabetes Mellitus. 2017;20(4):263–269. (In Russ.)]. doi: https://doi.org/10.14341/DM8328</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kylstra JA, Brown JC, Jaffe GJ, et al. The importance of fluorescein angiography in planning laser treatment of diabetic macular edema. Ophthalmology. 1999;106(11):2068-2073. doi: https://doi.org/10.1016/S0161-6420(99)90485-2</mixed-citation><mixed-citation xml:lang="en">Kylstra JA, Brown JC, Jaffe GJ, et al. The importance of fluorescein angiography in planning laser treatment of diabetic macular edema. Ophthalmology. 1999;106(11):2068-2073. doi: https://doi.org/10.1016/S0161-6420(99)90485-2</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Bresnick GH. Diabetic macular edema: A review. Ophthalmology. 1986;93:989-997. doi: https://doi.org/10.1016/s0161-6420(86)33650-9</mixed-citation><mixed-citation xml:lang="en">Bresnick GH. Diabetic macular edema: A review. Ophthalmology. 1986;93:989-997. doi: https://doi.org/10.1016/s0161-6420(86)33650-9</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Carpineto P, Mastropasqua R, Marchini G, et al. Reproducibility and repeatability of foveal avascular zone measurements in healthy subjects by optical coherence tomography angiography. Br J Ophthalmol. 2016;100(5):671-676. doi: https://doi.org/10.1136/bjophthalmol-2015-307330</mixed-citation><mixed-citation xml:lang="en">Carpineto P, Mastropasqua R, Marchini G, et al. Reproducibility and repeatability of foveal avascular zone measurements in healthy subjects by optical coherence tomography angiography. Br J Ophthalmol. 2016;100(5):671-676. doi: https://doi.org/10.1136/bjophthalmol-2015-307330</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hwang TS, Jia Y, Gao SS, et al. Optical coherence tomography angiography features of diabetic retinopathy. Retina. 2015;35(11):2371-2376. doi: https://doi.org/10.1097/IAE.0000000000000716</mixed-citation><mixed-citation xml:lang="en">Hwang TS, Jia Y, Gao SS, et al. Optical coherence tomography angiography features of diabetic retinopathy. Retina. 2015;35(11):2371-2376. doi: https://doi.org/10.1097/IAE.0000000000000716</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Hwang TS, Gao SS, Liu L, et al. Automated quantification of capillary nonperfusion using optical coherence tomography angiography in diabetic retinopathy. JAMA Ophthalmol. 2016;134(4):367-373. doi: https://doi.org/10.1001/jamaophthalmol.2015.5658</mixed-citation><mixed-citation xml:lang="en">Hwang TS, Gao SS, Liu L, et al. Automated quantification of capillary nonperfusion using optical coherence tomography angiography in diabetic retinopathy. JAMA Ophthalmol. 2016;134(4):367-373. doi: https://doi.org/10.1001/jamaophthalmol.2015.5658</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Shahlaee A, Pefkianaki M, Hsu J, Ho AC. Measurement of foveal avascular zone dimensions and its reliability in healthy eyes using optical coherence tomography angiography. Am J Ophthalmol. 2016;161:50-55.e51. doi: https://doi.org/10.1016/j.ajo.2015.09.026</mixed-citation><mixed-citation xml:lang="en">Shahlaee A, Pefkianaki M, Hsu J, Ho AC. Measurement of foveal avascular zone dimensions and its reliability in healthy eyes using optical coherence tomography angiography. Am J Ophthalmol. 2016;161:50-55.e51. doi: https://doi.org/10.1016/j.ajo.2015.09.026</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Takase N, Nozaki M, Kato A, et al. Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography. Retina. 2015;35(11):2377-2383. doi: https://doi.org/10.1097/IAE.0000000000000849</mixed-citation><mixed-citation xml:lang="en">Takase N, Nozaki M, Kato A, et al. Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography. Retina. 2015;35(11):2377-2383. doi: https://doi.org/10.1097/IAE.0000000000000849</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Bradley PD, Sim DA, Keane PA, et al. The evaluation of diabetic macular ischemia using optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57(2):626-631. doi: https://doi.org/10.1167/iovs.15-18034</mixed-citation><mixed-citation xml:lang="en">Bradley PD, Sim DA, Keane PA, et al. The evaluation of diabetic macular ischemia using optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57(2):626-631. doi: https://doi.org/10.1167/iovs.15-18034</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Couturier A, Mane V, Bonnin S, et al. Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography. Retina. 2015;35(11):2384-2391. doi: https://doi.org/10.1097/IAE.0000000000000859</mixed-citation><mixed-citation xml:lang="en">Couturier A, Mane V, Bonnin S, et al. Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography. Retina. 2015;35(11):2384-2391. doi: https://doi.org/10.1097/IAE.0000000000000859</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, et al. Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017;237(4):185-122. doi: https://doi.org/10.1159/000458539</mixed-citation><mixed-citation xml:lang="en">Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, et al. Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017;237(4):185-122. doi: https://doi.org/10.1159/000458539</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kozak I, El-Emam SY, Cheng L, et al. Fluorescein angiography versus optical coherence tomography-guided planning for macular laser photocoagulation in diabetic macular edema. Retina. 2014;34(8):1600-1605. doi: https://doi.org/10.1097/IAE.0000000000000120</mixed-citation><mixed-citation xml:lang="en">Kozak I, El-Emam SY, Cheng L, et al. Fluorescein angiography versus optical coherence tomography-guided planning for macular laser photocoagulation in diabetic macular edema. Retina. 2014;34(8):1600-1605. doi: https://doi.org/10.1097/IAE.0000000000000120</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt-Erfurth U, Chong V, Loewenstein A, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014;98(9):1144-1167. doi: https://doi.org/10.1136/bjophthalmol-2014-305702</mixed-citation><mixed-citation xml:lang="en">Schmidt-Erfurth U, Chong V, Loewenstein A, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014;98(9):1144-1167. doi: https://doi.org/10.1136/bjophthalmol-2014-305702</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Gerendas B, Simader C, Deak GG, et al. Morphological parameters relevant for visual and anatomic outcomes during anti-VEGF therapy of diabetic macular edema in the RESTORE trial. Invest Ophthalmol Vis Sci. 2014;55:1791-1791.</mixed-citation><mixed-citation xml:lang="en">Gerendas B, Simader C, Deak GG, et al. Morphological parameters relevant for visual and anatomic outcomes during anti-VEGF therapy of diabetic macular edema in the RESTORE trial. Invest Ophthalmol Vis Sci. 2014;55:1791-1791.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Bolz M, Kriechbaum K, Simader C, et al. In vivo retinal morphology after grid laser treatment in diabetic macular edema. Ophthalmology. 2010;117(3):538-544. doi: https://doi.org/10.1016/j.ophtha.2009.07.035</mixed-citation><mixed-citation xml:lang="en">Bolz M, Kriechbaum K, Simader C, et al. In vivo retinal morphology after grid laser treatment in diabetic macular edema. Ophthalmology. 2010;117(3):538-544. doi: https://doi.org/10.1016/j.ophtha.2009.07.035</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801. doi: https://doi.org/10.1016/j.ophtha.2011.12.039</mixed-citation><mixed-citation xml:lang="en">Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801. doi: https://doi.org/10.1016/j.ophtha.2011.12.039</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The restore study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615-625. doi: https://doi.org/10.1016/j.ophtha.2011.01.031</mixed-citation><mixed-citation xml:lang="en">Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The restore study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615-625. doi: https://doi.org/10.1016/j.ophtha.2011.01.031</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Lang GE, Berta A, Eldem BM, et al. Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study. Ophthalmology. 2013;120(10):2004-2012. doi: https://doi.org/10.1016/j.ophtha.2013.02.019</mixed-citation><mixed-citation xml:lang="en">Lang GE, Berta A, Eldem BM, et al. Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study. Ophthalmology. 2013;120(10):2004-2012. doi: https://doi.org/10.1016/j.ophtha.2013.02.019</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt-Erfurth U, Lang GE, Holz FG, et al. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology. 2014; 121(5):1045-1053. doi: https://doi.org/10.1016/j.ophtha.2013.11.041</mixed-citation><mixed-citation xml:lang="en">Schmidt-Erfurth U, Lang GE, Holz FG, et al. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology. 2014; 121(5):1045-1053. doi: https://doi.org/10.1016/j.ophtha.2013.11.041</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064-1077.e1035. doi: https://doi.org/10.1016/j.ophtha.2010.02.031</mixed-citation><mixed-citation xml:lang="en">Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064-1077.e1035. doi: https://doi.org/10.1016/j.ophtha.2010.02.031</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Korobelnik JF, Do DV, Schmidt-Erfurth U, et al.Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014;121(11):2247–2254. doi: https://doi.org/10.1016/j.ophtha.2014.05.006</mixed-citation><mixed-citation xml:lang="en">Korobelnik JF, Do DV, Schmidt-Erfurth U, et al.Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014;121(11):2247–2254. doi: https://doi.org/10.1016/j.ophtha.2014.05.006</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193-1203. doi: https://doi.org/10.1056/NEJMoa1414264</mixed-citation><mixed-citation xml:lang="en">Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193-1203. doi: https://doi.org/10.1056/NEJMoa1414264</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Prunte C, Fajnkuchen F, Mahmood S, et al. Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study. Br J Ophthalmol. 2016;100(6):787-795. doi: https://doi.org/10.1136/bjophthalmol-2015-307249</mixed-citation><mixed-citation xml:lang="en">Prunte C, Fajnkuchen F, Mahmood S, et al. Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study. Br J Ophthalmol. 2016;100(6):787-795. doi: https://doi.org/10.1136/bjophthalmol-2015-307249</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Pecen PE, Smith AG, Ehlers JP Optical Coherence Tomography Angiography of Acute Macular Neuroretinopathy/Paracentral Acute Middle Maculopathy. JAMA Ophthalmol. 2015 Dec; 133(12): 1478–1480. doi: 10.1001/jamaophthalmol.2015.4100</mixed-citation><mixed-citation xml:lang="en">Pecen PE, Smith AG, Ehlers JP Optical Coherence Tomography Angiography of Acute Macular Neuroretinopathy/Paracentral Acute Middle Maculopathy. JAMA Ophthalmol. 2015 Dec; 133(12): 1478–1480. doi: 10.1001/jamaophthalmol.2015.4100</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Sun JK, Lin MM, Lammer J, et al. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol. 2014;132(11):1309-1316. doi: https://doi.org/10.1001/jamaophthalmol.2014.2350</mixed-citation><mixed-citation xml:lang="en">Sun JK, Lin MM, Lammer J, et al. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol. 2014;132(11):1309-1316. doi: https://doi.org/10.1001/jamaophthalmol.2014.2350</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Shin HJ, Lee SH, Chung H, Kim HC. Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2012;250(1):61-70. doi: https://doi.org/10.1007/s00417-011-1774-x</mixed-citation><mixed-citation xml:lang="en">Shin HJ, Lee SH, Chung H, Kim HC. Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2012;250(1):61-70. doi: https://doi.org/10.1007/s00417-011-1774-x</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Bolz M, Schmidt-Erfurth U, Deak G, et al. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009;116(5):914-920. doi: https://doi.org/10.1016/j.ophtha.2008.12.039</mixed-citation><mixed-citation xml:lang="en">Bolz M, Schmidt-Erfurth U, Deak G, et al. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009;116(5):914-920. doi: https://doi.org/10.1016/j.ophtha.2008.12.039</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Gerendas BS, Waldstein SM, Simader C, et al. Three-dimensional automated choroidal volume assessment on standard spectral-domain optical coherence tomography and correlation with the level of diabetic macular edema. Am J Ophthalmol. 2014;158(5):1039-1048. doi: https://doi.org/10.1016/j.ajo.2014.08.001</mixed-citation><mixed-citation xml:lang="en">Gerendas BS, Waldstein SM, Simader C, et al. Three-dimensional automated choroidal volume assessment on standard spectral-domain optical coherence tomography and correlation with the level of diabetic macular edema. Am J Ophthalmol. 2014;158(5):1039-1048. doi: https://doi.org/10.1016/j.ajo.2014.08.001</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 1985;103(12):1796-1806</mixed-citation><mixed-citation xml:lang="en">Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 1985;103(12):1796-1806</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Kashani AH, Chen C-L, Gahm JK, et al. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications.Prog Retin Eye Res. 2017;60:66-100. doi: https://doi.org/10.1016/j.preteyeres.2017.07.002</mixed-citation><mixed-citation xml:lang="en">Kashani AH, Chen C-L, Gahm JK, et al. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications.Prog Retin Eye Res. 2017;60:66-100. doi: https://doi.org/10.1016/j.preteyeres.2017.07.002</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Chen CL, Gahm JK, Zheng F, Optical Coherence Tomography Angiography: A Comprehensive Review of Current Methods and Clinical Applications.</mixed-citation><mixed-citation xml:lang="en">Chen CL, Gahm JK, Zheng F, Optical Coherence Tomography Angiography: A Comprehensive Review of Current Methods and Clinical Applications.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical Coherence Tomography Angiography in a diabetic retinopathy: A prospective study. Am J Ophthalmol. 2015;160(1):35-44.e1. doi: https://doi.org/10.1016/j.ajo.2015.04.021</mixed-citation><mixed-citation xml:lang="en">Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical Coherence Tomography Angiography in a diabetic retinopathy: A prospective study. Am J Ophthalmol. 2015;160(1):35-44.e1. doi: https://doi.org/10.1016/j.ajo.2015.04.021</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Chen CL, Wang RK. Optical coherence tomography based angiography [Invited]. Biomed Opt Express. 2017;8(2):1056-1082. doi: https://doi.org/10.1364/BOE.8.001056</mixed-citation><mixed-citation xml:lang="en">Chen CL, Wang RK. Optical coherence tomography based angiography [Invited]. Biomed Opt Express. 2017;8(2):1056-1082. doi: https://doi.org/10.1364/BOE.8.001056</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell JP, Zhang M, Hwang TS, et al. Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography. Sci Rep. 2017;7:42201. doi: https://doi.org/10.1038/srep42201</mixed-citation><mixed-citation xml:lang="en">Campbell JP, Zhang M, Hwang TS, et al. Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography. Sci Rep. 2017;7:42201. doi: https://doi.org/10.1038/srep42201</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Chalam KV, Sambhav K. Optical coherence tomography angiography in retinal diseases. J Ophthalmic Vis Res. 2016;11(1):84-92. doi: https://doi.org/10.4103/2008-322X.180709</mixed-citation><mixed-citation xml:lang="en">Chalam KV, Sambhav K. Optical coherence tomography angiography in retinal diseases. J Ophthalmic Vis Res. 2016;11(1):84-92. doi: https://doi.org/10.4103/2008-322X.180709</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Thorell M, Zhang Q, Huang Y, et al. «Swept-source OCT angiography of macular telangiectasia type 2. Ophthalmic Surg Lasers Imaging Retina. 2014;45(5):369-380. doi: https://doi.org/10.3928/23258160-20140909-06</mixed-citation><mixed-citation xml:lang="en">Thorell M, Zhang Q, Huang Y, et al. «Swept-source OCT angiography of macular telangiectasia type 2. Ophthalmic Surg Lasers Imaging Retina. 2014;45(5):369-380. doi: https://doi.org/10.3928/23258160-20140909-06</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Spaide RF, Klancnik JM Jr, Cooney MJ, et al. Volume-rendering optical coherence tomography angiography of macular telangiectasia type 2. Ophthalmology. 2015;122(11):2261-2269. doi: https://doi.org/10.1016/j.ophtha.2015.07.025</mixed-citation><mixed-citation xml:lang="en">Spaide RF, Klancnik JM Jr, Cooney MJ, et al. Volume-rendering optical coherence tomography angiography of macular telangiectasia type 2. Ophthalmology. 2015;122(11):2261-2269. doi: https://doi.org/10.1016/j.ophtha.2015.07.025</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Nemiroff М, Kuehlewein, Rahimy E, et al. Assessing deep retinal capillary ischemia in paracentral acute middle maculopathy by optical coherence tomography angiography. Am J Ophtalmol. 2016;162:121-132. doi: https://doi.org/10.1016/j.ajo.2015.10.026</mixed-citation><mixed-citation xml:lang="en">Nemiroff М, Kuehlewein, Rahimy E, et al. Assessing deep retinal capillary ischemia in paracentral acute middle maculopathy by optical coherence tomography angiography. Am J Ophtalmol. 2016;162:121-132. doi: https://doi.org/10.1016/j.ajo.2015.10.026</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Moysidis SN, Koulisis N, Ameri H, et al. Multimodal imaging of geographic areas of retinal darkening. Retin Cases Brief Rep. 2015;9(4):347-351. doi: https://doi.org/10.1097/ICB.0000000000000231</mixed-citation><mixed-citation xml:lang="en">Moysidis SN, Koulisis N, Ameri H, et al. Multimodal imaging of geographic areas of retinal darkening. Retin Cases Brief Rep. 2015;9(4):347-351. doi: https://doi.org/10.1097/ICB.0000000000000231</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
